Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.45 USD | +5.37% | +0.72% | -20.10% |
Financials (USD)
Sales 2024 * | 293M | Sales 2025 * | 354M | Capitalization | 1.7B |
---|---|---|---|---|---|
Net income 2024 * | -180M | Net income 2025 * | -159M | EV / Sales 2024 * | 5.22 x |
Net cash position 2024 * | 174M | Net cash position 2025 * | 139M | EV / Sales 2025 * | 4.42 x |
P/E ratio 2024 * |
-9.58
x | P/E ratio 2025 * |
-11.2
x | Employees | 919 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.22% |
Latest transcript on Twist Bioscience Corporation
1 day | +5.37% | ||
1 week | +0.72% | ||
Current month | -14.16% | ||
1 month | -14.88% | ||
3 months | -15.28% | ||
6 months | +75.82% | ||
Current year | -20.10% |
Managers | Title | Age | Since |
---|---|---|---|
William Banyai
FOU | Founder | 69 | 13-02-03 |
Emily Leproust
CEO | Chief Executive Officer | 50 | 13-03-31 |
Adam Laponis
DFI | Director of Finance/CFO | 47 | Jan. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Ragusa
BRD | Director/Board Member | 64 | 16-10-31 |
Jan Johannessen
BRD | Director/Board Member | 67 | 18-09-30 |
Keith Crandell
BRD | Director/Board Member | 63 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.68% | 1 M€ | 0.00% | - | |
1.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 29.45 | +5.37% | 935,699 |
24-04-19 | 27.95 | -1.45% | 1,089,838 |
24-04-18 | 28.36 | -0.74% | 807,826 |
24-04-17 | 28.57 | -0.14% | 837,768 |
24-04-16 | 28.61 | -2.15% | 871,062 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.10% | 1.7B | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
-24.99% | 28.22B | |
+54.94% | 24.64B | |
-7.19% | 16.98B | |
-34.20% | 13.29B | |
-17.31% | 11.66B | |
-11.43% | 11.65B | |
-0.97% | 8.18B |
- Stock Market
- Equities
- TWST Stock